You are here

  • Home
  • Archive
  • Volume 52, Issue 6
  • Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study

Citation Tools

Article menu

This article has corrections. Please see:

Download PDFPDF
Stomach
Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Hawkey CJ, Laine L, Simon T on behalf of the Rofecoxib Rheumatoid Arthritis Endoscopy Study Group, et al
Incidence of gastroduodenal ulcers in patients with rheumatoid arthritis after 12 weeks of rofecoxib, naproxen, or placebo: a multicentre, randomised, double blind study
Gut 2003;52:820-826.